相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
Sarah Mejer Sorensen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study
Sudha Sundar et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece
Dimitrios Haidopoulos et al.
SURGICAL ONCOLOGY-OXFORD (2022)
Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer
Kati Kuusela et al.
EJSO (2022)
Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?
Ciro Pinelli et al.
JOURNAL OF INVESTIGATIVE SURGERY (2021)
Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy
Deepa M. Narasimhulu et al.
GYNECOLOGIC ONCOLOGY (2021)
Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA)
N. M. S. Baldewpersad Tewarie et al.
GYNECOLOGIC ONCOLOGY (2021)
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery
Christina Fotopoulou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
V Ghirardi et al.
GYNECOLOGIC ONCOLOGY (2020)
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial
Takashi Onda et al.
EUROPEAN JOURNAL OF CANCER (2020)
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Susana Banerjee et al.
ESMO OPEN (2020)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N. Colombo et al.
ANNALS OF ONCOLOGY (2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N. Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome
Marcia Hall et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
Alexander Reuss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-angiogenic agents in ovarian cancer: past, present, and future
B. J. Monk et al.
ANNALS OF ONCOLOGY (2016)
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities
Christina Fotopoulou et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease
Pauline Wimberger et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Quality Improvement in the Surgical Approach to Advanced Ovarian Cancer: The Mayo Clinic Experience
Giovanni D. Aletti et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer
Giovanni D. Aletti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
DS Chi et al.
GYNECOLOGIC ONCOLOGY (2004)